{"id":600840,"date":"2022-05-19T20:24:01","date_gmt":"2022-05-19T20:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=600840"},"modified":"2022-05-19T20:24:01","modified_gmt":"2022-05-19T20:24:01","slug":"nonhormonal-alternatives-for-menopause-market-size-estimated-to-reach-usd-13465-mn-by-2028-with-75-cagr-statistics-report-by-credence-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nonhormonal-alternatives-for-menopause-market-size-estimated-to-reach-usd-13465-mn-by-2028-with-75-cagr-statistics-report-by-credence-research_600840.html","title":{"rendered":"Non-Hormonal Alternatives for Menopause Market Size Estimated to Reach USD 13,465 Mn By 2028, With 7.5% CAGR: Statistics Report by Credence Research"},"content":{"rendered":"
\"Non-Hormonal<\/a><\/div>\n
The demand for Non-Hormonal Alternatives for Menopause is likely to exhibit rapid CAGR of over 7.5% over the forecast period to reach the valuation of USD 13,465 million in 2028.<\/div>\n

The Global Non-Hormonal Alternatives for Menopause Market generated revenue of around USD 7,929.16 million in 2021 and is anticipated to grow a CAGR of over 7.57% during the forecast period from 2022 to 2028 to reach around USD 13,465.59 million in 2028. While, cumulative growth opportunity presented by the global Non-Hormonal Alternatives for Menopause is around USD 76.6 billion during 2022 to 2028.<\/p>\n

Global Non-Hormonal Alternatives for Menopause Market, 2021 – 2028 (USD Million)<\/strong><\/p>\n

Non-Hormonal Alternatives for Menopause has been emerged as an effective replacement of hormonal therapy to be used to treat menopause in women. Large percentage of women face health problems associated with menopause such as mood swings, depression, anxiety, hot flashes, etc. Systemic hormonal therapy has been widely accepted to treat menopause. However, there are certain serious concerns related to hormonal therapy for menopause.<\/p>\n

Browse the full report at  https:\/\/www.credenceresearch.com\/report\/non-hormonal-alternatives-for-menopause-market<\/a><\/strong><\/p>\n

Hot Flashes to Held the Considerable Share in Global Non-Hormonal Alternatives for Menopause Market<\/strong><\/p>\n

Hot Flashes and Others (Chills, Night Sweats, Sleep Problems, Mood Changes, etc.) are some of the major indication segments of Non-Hormonal Alternatives for Menopause market by indication. Hot Flashes  is major segments by type in Non-Hormonal Alternatives for Menopause market. On the other hand, Chills, Night Sweats, Sleep Problems, Mood Changes, etc. is likely to grow in its market at rapid pace over the forecast period.<\/p>\n

Antidepressants to Lead the Growth of Non-Hormonal Alternatives for Menopause Market<\/strong><\/p>\n

Selective serotonin reuptake inhibitors (SSRIs), Selective serotonin-norepinephrine reuptake inhibitors (SNRIs), Plant-derived estrogens (phytoestrogens), Herbal treatments, Over-the-counter therapies and Others are therapies of global Non-Hormonal Alternatives for Menopause. Antidepressants such as  Selective serotonin reuptake inhibitors (SSRIs) and Selective serotonin-norepinephrine reuptake inhibitors (SNRIs) accounted major segment of the Non-Hormonal Alternatives for Menopause industry. While Herbal treatments also held the significant share in Non-Hormonal Alternatives for Menopause in 2021. It accounted for over 20% share in total revenue generated by the global Non-Hormonal Alternatives for Menopause  market in 2021. While, Plant-derived estrogens for Non-Hormonal Alternatives for Menopause is expected exhibit highest CAGR over the forecast period.<\/p>\n

Healthy Women to Hold Largest Share of Non-Hormonal Alternatives for Menopause Industry<\/strong><\/p>\n

Healthy Women and Breast cancer survivors are some of the major end-users of Non-Hormonal Alternatives for Menopause. Healthy Women’s segment held over 80% share in total revenue generated by the Non-Hormonal Alternatives for Menopause market across the world. While, Breast cancer survivors’ women segment is going to be the second leading end-user segment for the global Non-Hormonal Alternatives for Menopause market.<\/p>\n

U.S. is Leading Non-Hormonal Alternatives for Menopause Demand<\/strong><\/p>\n

U.S. is leading the demand for Non-Hormonal Alternatives for Menopause with Australia, China, South Korea, Japan, UK, France, Germany and Singapore being at the forefront of Non-Hormonal Alternatives for Menopause adoption. Asia Pacific will exhibit the fastest CAGR over the forecast period. Huge investment incurred by the companies and presence of large consumer base for Non-Hormonal Alternatives for Menopause, the demand in the above mentioned regions will be higher in the years to come.<\/p>\n

Major players operating in the global Non-Hormonal Alternatives for Menopause  market include Swor Women’s Care, Paladin Labs, Boehringer Ingelheim, Pfizer, Organon Inc., Lupin and GSK. Global Non-Hormonal Alternatives for Menopause market is characterized by the presence of large number of players across the world and is highly fragmented as well.<\/p>\n

Inquiry on this Report Before Purchase @ <\/strong>https:\/\/www.credenceresearch.com\/inquiry-before-buying\/60540<\/a><\/p>\n

Non-Hormonal Alternatives for Menopause Market<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Report Attribute<\/strong><\/p>\n<\/td>\n

\n

Details<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/thead>\n

\n

Market Value in 2021<\/p>\n<\/td>\n

\n

USD 7,929.16 million<\/p>\n<\/td>\n<\/tr>\n

\n

Market Value in 2028<\/p>\n<\/td>\n

\n

USD 13,465.59 million<\/p>\n<\/td>\n<\/tr>\n

\n

CAGR<\/p>\n<\/td>\n

\n

7.57% between 2021 and 2028<\/p>\n<\/td>\n<\/tr>\n

\n

Benchmarking Year<\/p>\n<\/td>\n

\n

2021<\/p>\n<\/td>\n<\/tr>\n

\n

Forecast period<\/p>\n<\/td>\n

\n

2022 – 2028<\/p>\n<\/td>\n<\/tr>\n

\n

Report coverage<\/p>\n<\/td>\n

\n

Market Size Valuation, Share Analysis and Growth Rate by Segments such as Indication and End-user, Company Share, Competitive Landscape and Trends Analysis<\/p>\n<\/td>\n<\/tr>\n

\n

Segments covered<\/p>\n<\/td>\n

\n

Indication<\/p>\n

Hot Flashes<\/p>\n

Others<\/p>\n

End-user<\/p>\n

Health Women<\/p>\n

Breast cancer survivors<\/p>\n

Therapy<\/p>\n

Selective serotonin reuptake inhibitors (SSRIs)<\/p>\n

Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)<\/p>\n

Plant-derived estrogens (phytoestrogens)<\/p>\n

Herbal treatments<\/p>\n

Over-the-counter therapies<\/p>\n

Others<\/p>\n<\/td>\n<\/tr>\n

\n

Major Players Analysed<\/p>\n<\/td>\n

\n

Salted Venture, Adidas, Digitsole, Pepper Gate Footwear Inc., PUMA SE (KERING), Xiaomi Corporation Limited, Zhor-Tech, Nike, Inc., ShiftWear, TRAQshoes, Under Armour, Inc. and Vivobarefoot Limited<\/p>\n<\/td>\n<\/tr>\n

\n

Cost of the Report<\/p>\n<\/td>\n

\n

Write us at sales@credenceresearch.com<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Sample of report with TOC @ <\/strong>https:\/\/www.credenceresearch.com\/sample-request\/60540<\/a><\/p>\n

Market Segmentation<\/strong><\/p>\n

Global Non-Hormonal Alternatives for Menopause Market by Indication, 2016 – 2028<\/strong><\/p>\n